The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Ophthalmology Drugs & Devices-Global Market Insights and Sales Trends 2024

Ophthalmology Drugs & Devices-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1850727

No of Pages : 115

Ask Your Query
Synopsis
Ophthalmology is a branch of medicine and surgery (both methods are used) that deals with the anatomy, physiology and diseases of the eyeball and orbit. Ophthalmic Equipment are the tool used for ophthalmology.
The global Ophthalmology Drugs & Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ophthalmology Drugs & Devices in various end use industries. The expanding demands from the Hospitals, Specialty Clinics and Ambulatory Surgical Centers (ASCs),, are propelling Ophthalmology Drugs & Devices market. Diagnostic and Monitoring Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Surgical Devices segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ophthalmology Drugs & Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ophthalmology Drugs & Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ophthalmology Drugs & Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ophthalmology Drugs & Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ophthalmology Drugs & Devices covered in this report include Abbott, Alcon, Allergan, Bausch & Lomb, Carl Zeiss Meditec, Ellex, Essilor, Hoya and Iridex, etc.
The global Ophthalmology Drugs & Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Alcon
Allergan
Bausch & Lomb
Carl Zeiss Meditec
Ellex
Essilor
Hoya
Iridex
Johnson & Johnson
Merck & Co.
Nidek Co.
Santen Pharmaceutical
Novartis
Pfizer
Roche Holding
Staar Surgical
Topcon
Ziemer Ophthalmic Systems
Global Ophthalmology Drugs & Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ophthalmology Drugs & Devices market, Segment by Type:
Diagnostic and Monitoring Devices
Surgical Devices
Vision Care Product
Ophthalmology Drugs
Global Ophthalmology Drugs & Devices market, by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers (ASCs)
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ophthalmology Drugs & Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ophthalmology Drugs & Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Ophthalmology Drugs & Devices Market Overview
1.1 Ophthalmology Drugs & Devices Product Overview
1.2 Ophthalmology Drugs & Devices Market Segment by Type
1.2.1 Diagnostic and Monitoring Devices
1.2.2 Surgical Devices
1.2.3 Vision Care Product
1.2.4 Ophthalmology Drugs
1.3 Global Ophthalmology Drugs & Devices Market Size by Type
1.3.1 Global Ophthalmology Drugs & Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Ophthalmology Drugs & Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Ophthalmology Drugs & Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ophthalmology Drugs & Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Ophthalmology Drugs & Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Ophthalmology Drugs & Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Ophthalmology Drugs & Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Ophthalmology Drugs & Devices Sales Breakdown by Type (2018-2023)
2 Global Ophthalmology Drugs & Devices Market Competition by Company
2.1 Global Top Players by Ophthalmology Drugs & Devices Sales (2018-2023)
2.2 Global Top Players by Ophthalmology Drugs & Devices Revenue (2018-2023)
2.3 Global Top Players by Ophthalmology Drugs & Devices Price (2018-2023)
2.4 Global Top Manufacturers Ophthalmology Drugs & Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ophthalmology Drugs & Devices Market Competitive Situation and Trends
2.5.1 Ophthalmology Drugs & Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Ophthalmology Drugs & Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ophthalmology Drugs & Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Ophthalmology Drugs & Devices Market
2.8 Key Manufacturers Ophthalmology Drugs & Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ophthalmology Drugs & Devices Status and Outlook by Region
3.1 Global Ophthalmology Drugs & Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Ophthalmology Drugs & Devices Historic Market Size by Region
3.2.1 Global Ophthalmology Drugs & Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Ophthalmology Drugs & Devices Sales in Value by Region (2018-2023)
3.2.3 Global Ophthalmology Drugs & Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Ophthalmology Drugs & Devices Forecasted Market Size by Region
3.3.1 Global Ophthalmology Drugs & Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Ophthalmology Drugs & Devices Sales in Value by Region (2024-2029)
3.3.3 Global Ophthalmology Drugs & Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Ophthalmology Drugs & Devices by Application
4.1 Ophthalmology Drugs & Devices Market Segment by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Ambulatory Surgical Centers (ASCs)
4.2 Global Ophthalmology Drugs & Devices Market Size by Application
4.2.1 Global Ophthalmology Drugs & Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Ophthalmology Drugs & Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Ophthalmology Drugs & Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ophthalmology Drugs & Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Ophthalmology Drugs & Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Ophthalmology Drugs & Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Ophthalmology Drugs & Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Ophthalmology Drugs & Devices Sales Breakdown by Application (2018-2023)
5 North America Ophthalmology Drugs & Devices by Country
5.1 North America Ophthalmology Drugs & Devices Historic Market Size by Country
5.1.1 North America Ophthalmology Drugs & Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Ophthalmology Drugs & Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Ophthalmology Drugs & Devices Sales in Value by Country (2018-2023)
5.2 North America Ophthalmology Drugs & Devices Forecasted Market Size by Country
5.2.1 North America Ophthalmology Drugs & Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Ophthalmology Drugs & Devices Sales in Value by Country (2024-2029)
6 Europe Ophthalmology Drugs & Devices by Country
6.1 Europe Ophthalmology Drugs & Devices Historic Market Size by Country
6.1.1 Europe Ophthalmology Drugs & Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Ophthalmology Drugs & Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Ophthalmology Drugs & Devices Sales in Value by Country (2018-2023)
6.2 Europe Ophthalmology Drugs & Devices Forecasted Market Size by Country
6.2.1 Europe Ophthalmology Drugs & Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Ophthalmology Drugs & Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Ophthalmology Drugs & Devices by Region
7.1 Asia-Pacific Ophthalmology Drugs & Devices Historic Market Size by Region
7.1.1 Asia-Pacific Ophthalmology Drugs & Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Ophthalmology Drugs & Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Ophthalmology Drugs & Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Ophthalmology Drugs & Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Ophthalmology Drugs & Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Ophthalmology Drugs & Devices Sales in Value by Region (2024-2029)
8 Latin America Ophthalmology Drugs & Devices by Country
8.1 Latin America Ophthalmology Drugs & Devices Historic Market Size by Country
8.1.1 Latin America Ophthalmology Drugs & Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Ophthalmology Drugs & Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Ophthalmology Drugs & Devices Sales in Value by Country (2018-2023)
8.2 Latin America Ophthalmology Drugs & Devices Forecasted Market Size by Country
8.2.1 Latin America Ophthalmology Drugs & Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Ophthalmology Drugs & Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Ophthalmology Drugs & Devices by Country
9.1 Middle East and Africa Ophthalmology Drugs & Devices Historic Market Size by Country
9.1.1 Middle East and Africa Ophthalmology Drugs & Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Ophthalmology Drugs & Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Ophthalmology Drugs & Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Ophthalmology Drugs & Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Ophthalmology Drugs & Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Ophthalmology Drugs & Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Ophthalmology Drugs & Devices Products Offered
10.1.5 Abbott Recent Development
10.2 Alcon
10.2.1 Alcon Company Information
10.2.2 Alcon Introduction and Business Overview
10.2.3 Alcon Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Alcon Ophthalmology Drugs & Devices Products Offered
10.2.5 Alcon Recent Development
10.3 Allergan
10.3.1 Allergan Company Information
10.3.2 Allergan Introduction and Business Overview
10.3.3 Allergan Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Allergan Ophthalmology Drugs & Devices Products Offered
10.3.5 Allergan Recent Development
10.4 Bausch & Lomb
10.4.1 Bausch & Lomb Company Information
10.4.2 Bausch & Lomb Introduction and Business Overview
10.4.3 Bausch & Lomb Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bausch & Lomb Ophthalmology Drugs & Devices Products Offered
10.4.5 Bausch & Lomb Recent Development
10.5 Carl Zeiss Meditec
10.5.1 Carl Zeiss Meditec Company Information
10.5.2 Carl Zeiss Meditec Introduction and Business Overview
10.5.3 Carl Zeiss Meditec Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Carl Zeiss Meditec Ophthalmology Drugs & Devices Products Offered
10.5.5 Carl Zeiss Meditec Recent Development
10.6 Ellex
10.6.1 Ellex Company Information
10.6.2 Ellex Introduction and Business Overview
10.6.3 Ellex Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ellex Ophthalmology Drugs & Devices Products Offered
10.6.5 Ellex Recent Development
10.7 Essilor
10.7.1 Essilor Company Information
10.7.2 Essilor Introduction and Business Overview
10.7.3 Essilor Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Essilor Ophthalmology Drugs & Devices Products Offered
10.7.5 Essilor Recent Development
10.8 Hoya
10.8.1 Hoya Company Information
10.8.2 Hoya Introduction and Business Overview
10.8.3 Hoya Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hoya Ophthalmology Drugs & Devices Products Offered
10.8.5 Hoya Recent Development
10.9 Iridex
10.9.1 Iridex Company Information
10.9.2 Iridex Introduction and Business Overview
10.9.3 Iridex Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Iridex Ophthalmology Drugs & Devices Products Offered
10.9.5 Iridex Recent Development
10.10 Johnson & Johnson
10.10.1 Johnson & Johnson Company Information
10.10.2 Johnson & Johnson Introduction and Business Overview
10.10.3 Johnson & Johnson Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Johnson & Johnson Ophthalmology Drugs & Devices Products Offered
10.10.5 Johnson & Johnson Recent Development
10.11 Merck & Co.
10.11.1 Merck & Co. Company Information
10.11.2 Merck & Co. Introduction and Business Overview
10.11.3 Merck & Co. Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Merck & Co. Ophthalmology Drugs & Devices Products Offered
10.11.5 Merck & Co. Recent Development
10.12 Nidek Co.
10.12.1 Nidek Co. Company Information
10.12.2 Nidek Co. Introduction and Business Overview
10.12.3 Nidek Co. Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Nidek Co. Ophthalmology Drugs & Devices Products Offered
10.12.5 Nidek Co. Recent Development
10.13 Santen Pharmaceutical
10.13.1 Santen Pharmaceutical Company Information
10.13.2 Santen Pharmaceutical Introduction and Business Overview
10.13.3 Santen Pharmaceutical Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Santen Pharmaceutical Ophthalmology Drugs & Devices Products Offered
10.13.5 Santen Pharmaceutical Recent Development
10.14 Novartis
10.14.1 Novartis Company Information
10.14.2 Novartis Introduction and Business Overview
10.14.3 Novartis Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Novartis Ophthalmology Drugs & Devices Products Offered
10.14.5 Novartis Recent Development
10.15 Pfizer
10.15.1 Pfizer Company Information
10.15.2 Pfizer Introduction and Business Overview
10.15.3 Pfizer Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Pfizer Ophthalmology Drugs & Devices Products Offered
10.15.5 Pfizer Recent Development
10.16 Roche Holding
10.16.1 Roche Holding Company Information
10.16.2 Roche Holding Introduction and Business Overview
10.16.3 Roche Holding Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Roche Holding Ophthalmology Drugs & Devices Products Offered
10.16.5 Roche Holding Recent Development
10.17 Staar Surgical
10.17.1 Staar Surgical Company Information
10.17.2 Staar Surgical Introduction and Business Overview
10.17.3 Staar Surgical Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Staar Surgical Ophthalmology Drugs & Devices Products Offered
10.17.5 Staar Surgical Recent Development
10.18 Topcon
10.18.1 Topcon Company Information
10.18.2 Topcon Introduction and Business Overview
10.18.3 Topcon Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Topcon Ophthalmology Drugs & Devices Products Offered
10.18.5 Topcon Recent Development
10.19 Ziemer Ophthalmic Systems
10.19.1 Ziemer Ophthalmic Systems Company Information
10.19.2 Ziemer Ophthalmic Systems Introduction and Business Overview
10.19.3 Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Products Offered
10.19.5 Ziemer Ophthalmic Systems Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ophthalmology Drugs & Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ophthalmology Drugs & Devices Industrial Chain Analysis
11.4 Ophthalmology Drugs & Devices Market Dynamics
11.4.1 Ophthalmology Drugs & Devices Industry Trends
11.4.2 Ophthalmology Drugs & Devices Market Drivers
11.4.3 Ophthalmology Drugs & Devices Market Challenges
11.4.4 Ophthalmology Drugs & Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ophthalmology Drugs & Devices Distributors
12.3 Ophthalmology Drugs & Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock